Skip to main content Back to Top


Docusate Sodium Oral Liquid in Bulk Bottles

Products Affected - Description

    • Diocto oral liquid, Geri-Care, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0403-16 - discontinued
    • Diocto oral syrup, Geri-Care, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0409-16 - discontinued
    • Docu Liquid oral liquid, Akorn, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 50383-0771-16
    • Silace oral liquid, Lannett, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0116-80
    • Silace oral syrup, Lannett, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0107-80

Reason for the Shortage

    • Akorn has Docu Liquid on shortage because they are waiting on raw ingredients.
    • Geri-Care had a contract manufacturer shut down. The company has discontinued Diocto syrup and liquid.
    • Lannett did not provide a reason for the shortage.
    • Docusate sodium 10 mL unit dose cups are not affected.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Akorn has Docu Liquid in 473 mL bottles on back order and the company estimates a release date of late-February 2020. Product is being allocated as it becomes available.
    • Geri-Care discontinued Diocto liquid in 473 mL bottles the company plans to relaunch the product in the 2nd or 3rd quarter of 2020.
    • Lannett has Silace 50 mg/5 mL liquid and 60 mg/15 mL syrup in 473 mL bottles on allocation.


Updated February 5, 2020 by Megan Dryer, PharmD. Created August 19, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins